Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory?

doi:10.4329/wjr.v5.i7.259

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5737)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

327

HTML

2805

Figures (1-3)

245

Tables (1-1)

346

Sum=3723

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1012

Download

1002

Sum=2014

Jul 28, 2013 (publication date) through Jul 20, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Radiol. Jul 28, 2013; 5(7): 259-263
Published online Jul 28, 2013. doi: 10.4329/wjr.v5.i7.259

Full Size Figure Download Figure

Figure 1 Flowchart of patient inclusion. Total of 70 patients were selected randomly out of the hyoscine-N-butyl-bromide (HBB) and the corresponding control group. MRI: Magnetic resonance imaging.

Citation: Roethke MC, Kuru TH, Radbruch A, Hadaschik B, Schlemmer HP. Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory? World J Radiol 2013; 5(7): 259-263
URL: https://www.wjgnet.com/1949-8470/full/v5/i7/259.htm
DOI: https://dx.doi.org/10.4329/wjr.v5.i7.259